Category Research

Commending Ten Years of the Severe Acute Respiratory Infections Network in the Americas

The Severe Acute Respiratory Infections Network (SARInet) is a regional collaboration comprising professionals from hospitals, laboratories, health organizations, and institutions across Member States of the Americas. SARInet, coordinated by the Pan American Health Organization/World Health Organization (PAHO/WHO), marked its 10th…

Read MoreCommending Ten Years of the Severe Acute Respiratory Infections Network in the Americas

Genexine and EPD Biotherapeutics Merge to Enhance Drug Development Pipeline

Genexine (KOSDAQ: 095700), a Korean clinical-stage biopharmaceutical firm dedicated to developing innovative biologics for critical medical needs, has announced a merger with EPD Biotherapeutics (referred to as ‘EPD Bio’), a pioneer in targeted protein degradation (TPD) bioPROTAC platform technology. This…

Read MoreGenexine and EPD Biotherapeutics Merge to Enhance Drug Development Pipeline

Owkin, an AI-Biotech Unicorn, Expands to Germany, Austria, and Switzerland to Accelerate Research with Cutting-Edge AI

Owkin, the first end-to-end AI-biotech unicorn specializing in AI-driven precision drug discovery, development, and diagnostics, has announced its expansion into the DACH region (Germany, Austria, and Switzerland). This follows partnerships with nine top centers in the region, including Charité –…

Read MoreOwkin, an AI-Biotech Unicorn, Expands to Germany, Austria, and Switzerland to Accelerate Research with Cutting-Edge AI

Owkin, Leading AI-Biotech Innovator, Expands Cutting-Edge AI to Germany, Austria, and Switzerland to Advance Research

Owkin, the pioneering AI-biotech unicorn specializing in AI-driven precision drug discovery, development, and diagnostics, has launched its expansion into the DACH region (Germany, Austria, and Switzerland). This expansion follows strategic partnerships with nine leading institutions in the region, including Charité…

Read MoreOwkin, Leading AI-Biotech Innovator, Expands Cutting-Edge AI to Germany, Austria, and Switzerland to Advance Research

LEQEMBI® (Lecanemab) Launches in China for Alzheimer’s Disease Treatment

Biogen, headquartered in Cambridge, Massachusetts, and led by CEO Christopher A. Viehbacher, announced today the launch of “LEQEMBI®” (known as “乐意保®” in China), a humanized anti-soluble aggregated amyloid-beta (Aβ) monoclonal antibody, in China. Approved in January 2024 for treating mild…

Read MoreLEQEMBI® (Lecanemab) Launches in China for Alzheimer’s Disease Treatment

Pfizer and BioNTech Granted Favorable CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union

Today, Pfizer and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the approval of their Omicron JN.1-adapted monovalent COVID-19 vaccine, COMIRNATY® JN.1, for active immunization against COVID-19 caused…

Read MorePfizer and BioNTech Granted Favorable CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union

Augustine Therapeutics Secures EUR 17 Million in Series A Funding to Propel Lead Candidate into Clinical Development for Neurological Diseases

Augustine Therapeutics, a pioneering biotech firm dedicated to advancing treatments for neurodegenerative and cardiometabolic diseases, has successfully closed its Series A funding round with EUR 17 million (USD 18.5 million). Asabys Partners led the financing, joined by Eli Lilly and…

Read MoreAugustine Therapeutics Secures EUR 17 Million in Series A Funding to Propel Lead Candidate into Clinical Development for Neurological Diseases

BioStrand and PGxAI Partner to Develop AI Model for Pharmacogenomics with LENSai

ImmunoPrecise Antibodies Ltd. (IPA), an AI-driven biotherapeutic research and technology company, announced a strategic collaboration between its subsidiary, BioStrand, and PGxAI. This partnership aims to leverage BioStrand’s patented LENSai Foundation AI Model to advance pharmacogenomics, the study of how genetic…

Read MoreBioStrand and PGxAI Partner to Develop AI Model for Pharmacogenomics with LENSai

New Thermo Scientific Heracell Incubators Propel the Future of Fully Automated Labs

To advance workflow automation in cell therapy production, Thermo Fisher Scientific has launched the Thermo Scientific™ Heracell™ VIOS™ 250i AxD CO2 Incubators. These pioneering CO2 incubators are tailored for integration into automated and modular labs. Known for optimal cell growth…

Read MoreNew Thermo Scientific Heracell Incubators Propel the Future of Fully Automated Labs